Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
Iterum Therapeutics plc | Director | Ordinary Shares | 71.4 K | $100 K | $1.40 | Oct 1, 2023 | By New Leaf Ventures III, L.P. |
Iterum Therapeutics plc | Director | Ordinary Shares | 25.6 K | $35.9 K | $1.40 | Oct 1, 2023 | By New Leaf Biopharma Opportunities II, L.P. |
Harpoon Therapeutics, Inc. | Director, 10%+ Owner | Director Stock Option (Right to Buy) | 0 | $32.2 K | $1.40 | Mar 11, 2024 | Direct |
Rallybio Corp | Director | Option (Right to Buy) | 16.5 K | $29.2 K | $1.77 | May 15, 2024 | Direct |
Iterum Therapeutics plc | Director | Ordinary Shares | 14.3 K | $20.1 K | $1.40 | Oct 1, 2023 | Direct |
Harpoon Therapeutics, Inc. | Director, 10%+ Owner | Common Stock | 0 | $0 | $23.00 | Mar 11, 2024 | Direct |
Harpoon Therapeutics, Inc. | Director, 10%+ Owner | Common Stock | 0 | $0 | $23.00 | Mar 11, 2024 | Indirect |
Harpoon Therapeutics, Inc. | Director, 10%+ Owner | 8.000% Series A Redeemable Preferred Stock | 0 | Mar 11, 2024 | Indirect | ||
Harpoon Therapeutics, Inc. | Director, 10%+ Owner | Common Stock Warrant (Right to Buy) | 0 | Mar 11, 2024 | Indirect | ||
Iterum Therapeutics plc | Director | Restricted Share Units | 0 | Oct 1, 2023 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
RLYB | Rallybio Corp | May 15, 2024 | 1 | $0 | 4 | May 17, 2024 | Director |
HARP | Harpoon Therapeutics, Inc. | Mar 8, 2024 | 12 | $0 | 4 | Mar 11, 2024 | Director, 10%+ Owner |
RLYB | Rallybio Corp | Jan 2, 2024 | 1 | $51.5 K | 4 | Jan 4, 2024 | Director |
HARP | Harpoon Therapeutics, Inc. | Jan 1, 2024 | 1 | $0 | 4 | Jan 3, 2024 | Director, 10%+ Owner |
HARP | Harpoon Therapeutics, Inc. | Nov 27, 2023 | 1 | $0 | 4 | Nov 28, 2023 | Director, 10%+ Owner |
HARP | Harpoon Therapeutics, Inc. | Oct 25, 2023 | 4 | $0 | 4 | Oct 27, 2023 | Director, 10%+ Owner |
HARP | Harpoon Therapeutics, Inc. | Oct 1, 2023 | 1 | $0 | 4 | Oct 2, 2023 | Director, 10%+ Owner |
ITRM | Iterum Therapeutics plc | Oct 1, 2023 | 2 | $0 | 4 | Oct 2, 2023 | Director |
HARP | Harpoon Therapeutics, Inc. | Jul 1, 2023 | 1 | $0 | 4 | Jul 6, 2023 | Director, 10%+ Owner |
ITRM | Iterum Therapeutics plc | Jul 1, 2023 | 2 | $0 | 4 | Jul 3, 2023 | Director |
HARP | Harpoon Therapeutics, Inc. | Jun 22, 2023 | 1 | $0 | 4 | Jun 23, 2023 | Director, 10%+ Owner |
RLYB | Rallybio Corp | May 17, 2023 | 1 | $0 | 4 | May 19, 2023 | Director |
HARP | Harpoon Therapeutics, Inc. | Apr 1, 2023 | 1 | $0 | 4 | Apr 4, 2023 | Director, 10%+ Owner |
ITRM | Iterum Therapeutics plc | Apr 1, 2023 | 2 | $0 | 4 | Apr 3, 2023 | Director |
HARP | Harpoon Therapeutics, Inc. | Mar 23, 2023 | 2 | $10 M | 4 | Mar 27, 2023 | Director, 10%+ Owner |
RLYB | Rallybio Corp | Jan 3, 2023 | 1 | $0 | 4 | Jan 5, 2023 | Director |
ITRM | Iterum Therapeutics plc | Jan 1, 2023 | 2 | $0 | 4 | Jan 4, 2023 | Director |
ITRM | Iterum Therapeutics plc | Dec 23, 2022 | 1 | $0 | 4 | Dec 28, 2022 | Director |
ITRM | Iterum Therapeutics plc | Sep 25, 2022 | 1 | $0 | 4 | Sep 27, 2022 | Director |
ITRM | Iterum Therapeutics plc | Jun 25, 2022 | 1 | $0 | 4 | Jun 28, 2022 | Director |
ITRM | Iterum Therapeutics plc | Jun 23, 2022 | 2 | $0 | 4 | Jun 24, 2022 | Director |
HARP | Harpoon Therapeutics, Inc. | Jun 22, 2022 | 2 | $45 K | 4 | Jun 24, 2022 | Director, 10%+ Owner |
ITRM | Iterum Therapeutics plc | Jun 15, 2022 | 1 | $6.47 K | 4 | Jun 17, 2022 | Director |
RLYB | Rallybio Corp | May 24, 2022 | 1 | $0 | 4 | May 26, 2022 | Director |
ITRM | Iterum Therapeutics plc | Mar 25, 2022 | 1 | $0 | 4 | Mar 29, 2022 | Director |
RLYB | Rallybio Corp | Jan 3, 2022 | 1 | $0 | 4 | Jan 5, 2022 | Director |
RLYB | Rallybio Corp | Jul 29, 2021 | 0 | $0 | 3 | Jul 29, 2021 | Director |
RLYB | Rallybio Corp | Jul 28, 2021 | 7 | $4 M | 4 | Aug 4, 2021 | Director |
ITRM | Iterum Therapeutics plc | Jun 23, 2021 | 1 | $0 | 4 | Jun 25, 2021 | Director |
HARP | Harpoon Therapeutics, Inc. | May 4, 2021 | 2 | $0 | 4/A | May 14, 2021 | Director, 10%+ Owner |
HARP | Harpoon Therapeutics, Inc. | Jan 11, 2021 | 1 | $4 M | 4 | Aug 12, 2021 | Director, 10%+ Owner |